Increasing knowledge about AID, understanding the AID-associated responses, both in B cells and tumor cells, might allow stratifying the prognosis of various cancer types and considering whether targeting of AID is beneficial for AID-positive tumors as suggested recently for plasmocytoma [64] and colitis-associated colon carcinogenesis [55]. Here, AICDA is linked to colitis.